Available Technologies
# of Displayed Technologies: 1 / 1
Categories
Rapid Viral Inactivation by Gingipains
TS-004565 — A method for proteolytic inactivation of respiratory syncytial virus (RSV) with bacterial proteases purified from oral bacteria Porphyromonas gingivalis. Thus, a potential new antiviral for treatment of severe RSV infection.
Respiratory syncytial virus (RSV) is highly ocntagious and the second leading cause of lower respiratory tract infections in children, requiring hospitalization of about 3% of children under age 2 and with a mortality rate reported to be approximately 5x higher than influenza. RSV also poses signifi…
- College:
- Inventors: Bagaitkar, Juhi; Peeples, Mark; Rodriguez-Hernandez, Carlos
- Licensing Officer: Zalucha, Ellen
